Заключение

Большинство используемых моделей гиперпролактинемии связано с предот- варщением действия ДА на лактотрофы гипофиза, что моделируется на гипоталамическом или гипофизарном уровне с помощью антагонистов ДА или с помощью нокаута гена рецепторов к ДА.

Литература

Бабичев В.Н. Половые гормоны и центральная нервная система // Pocc. хим. журнал. 2005. № 1. С. 94-103.

Дедов И.И., Мельниченко ГА., Романцова Т.И. Синдром гиперпролактинемии. М.-Тверь: Триада, 2004. 304 с.

Дильмухаметова Л.К., Пронина Т.С., Зиязетдинова Г.З. и др. Роль норадреналина в развитии дофа- мин-зависимой гиперпролактинемии. // Нейрохимия. 2009. Вып. 26. P 318-327.

Дильмухаметова Л.К., Пронина Т.С., Воробьева Н.Е. и др. Изменения функциональной активности лактотрофов при недостаточности дофаминергической системы гипоталамуса // Докл. РАН. 2010. Вып. 430. № 2. P 273-276.

Дильмухаметова Л.К., Пронина Т.С., Угрюмов М.В. Роль норадреналина в регуляции дофамин-про- дуцирующих нейронов аркуатного ядра у крыс // Росс. физиол. журнал им. И.М. Сеченова. 2012. Вып. 38. № 12. P 1507-1519.

Дильмухаметова Л.К., Пронина Т.С., Угрюмов М.В.

Зиязетдинова Г.З., Сапронова А.Я., Киясова В.Я. и др. Компенсаторная реакция при дегенерации до- фаминергических нейронов аркуатного ядра // Журнал эволюцю биохим. Физиол. 2008. Вып. 44. P. 72-77.

AbramovaM.A., CalasA., UgrumovM. Vasopressinergic neurons of the supraoptic nucleus in perinatal rats: reaction to osmotic stimulation and its regulation // Brain Structure & Function 2011. Vol. 215. № 3-4. P 195-207.

ArbogastL.A., Voogt J.L. Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta // Endocrinology. 1991. Vol. 128. P 997-1005.

Arendash G.W. Leung P.C. Alleviation of estrogen-induced hyperprolactinemia through intracerebral transplantation of hypothalamic tissue containing dopaminergic neurons // Neuroendocrinology. 1986. Vol. 43. № 3. P 359-367.

AsaS.L., KellyM.A., Grandy D.K., LowM.J. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice // Endocrinology. 1999. Vol. 140. P 5348-5355. Autelitano D.J., Snyder L., Sealfon S.C., Roberts J.L. Dopamine D2-receptor messenger RNA is differentially regulated by dopaminergic agents in rat anterior and neurointermediate pituitary // Mol. Cell Endocrinol. 1989. Vol. 67. P 101-105.

Bartholini G., Richards J.G., Pletscher A. Dissociation between biochemical and ultrastructural effects of 6-hydroxydopamine in rat brain // Experientia. 1970. Vol. 26. P. 142-144.

Ben-Jonathan N., Hnasko R. Dopamine as a prolactin (PRL) inhibitor // Endocr. Rev. 2001. Vol. 22. P. 724-763.

Biegon A., Rainbow T.C. Localization and characterization of [3H]desmethylimipramine binding sites in rat brain by quantitative autoradiography // J. Neurosci. 1983. Vol. 3. P. 1069-1076.

Blandini F., Armentero M.T., Martignoni E. The 6-hydroxy dopamine model: news from the past // Parkinsonism Relat.

Bosler O., Calas A. Radioautographic investigation of monoaminergic neurons: an evaluation // Brain Res. Bull. 1982. Vol. 9. P. 151-169.

Chahal J., Schlechte J. Hyperprolactinemia // Pituitary. 2008. Vol. 11. P. 141-146.

Clapp C. Torner L. Gutierrez-Ospina G. et al. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin // Proc. Natl. Acad. Sci. USA. 1994. Vol. 91. № 22. P. 10384-10388.

Colthorpe K.L., Nalliah J., Anderson S.T., Curlewis J.D. Adrenoceptor subtype involvement in suppression of prolactin secretion by noradrenaline // J. Neuroendocrinol. 2000. Vol. 12. P. 297-302.

Cristina C., Garcia-Tornadu I., Diaz-Torga G. et al. Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma // Front. Horm. Res. 2006. Vol. 35. P. 50-63.

Daikoku S., Kawano H., Okamura et al. Ontogenesis of immunoreactive tyrosine hydroxylase-containing neurons in rat hypothalamus // Dev. Brain Res. 1986. Vol. 393. № 1. P. 85-98.

Demarest K.T. Riegle G.D. Moore K.E. Long-term treatment with estradiol induces reversible alterations in tuberoinfundibular dopaminergic neurons: a decreased responsiveness to prolactin // Neuroendocrinology. 1984. Vol. 39. № 3. P 193-200.

DeMaria J.E. Nagy G.M. Freeman M.E. Immunoneutralization of prolactin prevents stimulatory feedback of prolactin on hypothalamic neuroendocrine dopaminergic neurons // Endocrine. 2000. Vol. 12. № 3. P. 333-337.

Emanuele N.V., Jurgens J.K., Halloran M.M. et al. The rat prolactin gene is expressed in brain tissue: detection of normal and alternatively spliced prolactin messenger RNA // Mol. Endocrinol. 1992. Vol. 6. № 1. P. 35-42.

Ershov P.V., Ugrumov M.V., Calas A., Krieger M., Thibaul, J. Differentiation of tyrosine hydroxylase-synthesizing and/or aromatic L-amino acid decarboxylase-synthesizing neurons in the rat mediobasal hypothalamus: quantitative double-immunofluorescence study // J.

Ershov P. V., Ugrumov M.V., Calas A. et al. Neurons possessing enzymes of dopamine synthesis in the mediobasal hypothalamus of rats. Topographic relations and axonal projections to the median eminence in ontogenesis // J. Chem. Neuroanat. 2002b. Vol. 24. № 2. P 95-107.

Ershov P. V., Ugrumov M.V., Calas A. et al. Degeneration of dopaminergic neurons triggers an expression of individual enzymes of dopamine synthesis in non-dopaminergic neurons of the arcuate nucleus in adult rats // J. Chem. Neuroanat. 2005. Vol. 30. P. 27-33.

Fekete M.I., Herman J.P., Kanyicska B., Palkovits M. Dopamine, noradrenaline and 3,4-dihydroxyphenyl- acetic acid (DOPAC) levels of individual brain nuclei, effects of haloperidol and pargyline // J. Neural. Transm. 1979. Vol. 45. P 207-218.

Fenske M., Wuttke W. Effects of intraventricular 6-hydroxydopamine injections on serum prolactin and LH levels: absence of stress-induced pituitary prolactin release // Brain Res. 1976. Vol. 104. P 63-70.

Flores C.M. Hulihan-Giblin B.A. Hornby P.J. Lumpkin M.D. Kellar K.J. Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin // Neuroendocrinology. 1992. Vol. 55. № 5. P 519-528.

Freeman M.E., Kanyicska B., Lerant A., Nagy G. Prolactin: structure, function, and regulation of secretion // Physiol. Rev. 2000. Vol. 80. P 1523-1631.

Fulceri F., Biagioni F., Lenzi P. et al. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures // Ann. NY Acad. Sci. 2006. Vol. 1074. P 344-348.

Hentges S.T., Low M.J. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice // Endocrinology. 2002. Vol. 143. P 4536-4543.

Johnston C.A., SpinediE.J., Negro-VilarA. Effect of acute ether stress on monoamine metabolism in median eminence and discrete hypothalamic nuclei of the rat brain and on anterior pituitary hormone secretion // Neuroendocrinology. 1985. Vol.

Jonsson G. Chemical lessions techniques: monoamine neurotoxins // Handbook of chemical neuroanatomy: Methods in chemical neuroanatomy. Eds. A. Biorklund, T. Hokfelt. Elsevier, 1983. P 463-507

Kelly M.A., Rubinstein M., Asa S.L. et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice // Neuron. 1997. Vol. 19. P. 103-113.

Lewinski A., Konopacki J., Pawlikowski M. et al. Effects of intraventricular injections of 6-hydroxy dopamine on anterior pituitary cell proliferation // Anat. Rec. 1984. Vol. 208. P. 421-426.

Machiavelli G.A., Jahn G.A., Kalbermann L.E. et al. Effect of haloperidol on the synthesis of DNA in the pituitary gland of the rat // Horm. Metab. Res. 1982. Vol. 14. P. 150-153.

McCann S.M., Lumpkin M.D., Mizunuma H. et al. Peptidergic and dopaminergic control of prolactin release // Trends Neurosci. 1984. Vol. 7. P. 127-131.

Missale C., Nash S.R., Robinson S.W. et al. Dopamine receptors: from structure to function // Physiol. Rev. 1998. Vol. 78. P. 189-225.

Mohankumar P.S., Mohankumar S.M., Quadri S.K., Voogt J.L. Chronic hyperprolactinemia and changes in dopamine neurons // Brain Res. Bull. 1997. Vol. 42. P. 435-441.

Mohankumar S.M. Kasturi B.S. Shin A.C. et al. Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia // Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010. Vol. 300. № 3. P. 693-699.

Morel G.R., Caron R.W., Console G.M. et al. Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage // Brain Res. Bull. 2009. Vol. 80. № 6. P. 347-352.

Okamura H., Kitahama K., Nagatsu I., GeffardM. Comparative topography of dopamine- and tyrosine hy- droxylase-immunoreactive neurons in the rat arcuate nucleus // Neurosci. Lett. 1988. Vol. 95. № 1-3. P. 347-3531.

Saiardi A., Bozzi Y., Baik J.H., Borrelli E. Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia // Neuron.

Sarkar D.K. Yen S.S. Hyperprolactinemia decreases the luteinizing hormone-releasing hormone concentration in pituitary portal plasma: a possible role for beta-endorphin as a mediator // Endocrinology. 1985. Vol. 166. № 5. P. 2080-2084.

Serri O., Chik C.L., Ur E., Ezzat S. Diagnosis and management of hyperprolactinemia // Cmaj. 2003. Vol. 169. P. 575-581.

Sheward W.J., Watts A.G., Fink G., Smith G.C. Effects of intravenously administered 6-hydroxy dopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat // Neurosci. Lett. 1985. Vol. 55. P. 141-144.

Torner L., Mejia S., Lopez-Gomez F.J. et al. A 14-kilodalton prolactin-like fragment is secreted by the hy- pothalamo-neurohypophyseal system of the rat // Endocrinology. 1995. Vol. 136. № 12. P. 5454-5460.

Troadec J.D., Marien M, Darios F. et al. Noradrenaline provides long-term. protection to dopaminergic neurons by reducing oxidative stress // J. Neurochem. 2001. Vol. 79. № 1. P. 200-210.

UgrumovM.V. Brain neurons partly expressing monoaminergic phenotype: distribution, development, and functional significance in norm and pathology. 3rd ed. Handbook of Neurochemistry and Molecular Neurobiology. Ed. A. Lajtha. Neurotransmitter Systems. Ed. S. Vizi. Heidelberg. Springer. 2008. P. 21-73.

Ugrumov M., Melnikova V., Ershov P., Balan I., Calas A. Tyrosine hydroxylase- and/or aromatic L-amino acid decarboxylase-expressing neurons in the rat arcuate nucleus: Ontogenesis and functional significance // Psychoneuroendocrinology. 2002. Vol. 27. № 5. P. 533-548.

Ugrumov M.V., Melnikova V.I., Lavrentyeva A.V. et al. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats // Neuroscience. 2004. Vol. 124. P. 629-635.

Ugrumov M.V., Taxi J., Pronina et al. Neuros expressing individual enzymes of dopamine synthesis in the mediobasal hypothalamus of adult rats: functional significance and topographic interrelations // Neurosci. 2014. Vol. 277. P. 45-54.

Yen S.H. Pan J.T. Nitric oxide plays an important role in the diurnal change of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in ovariectomized, estrogen/progesterone-treated rats // Endocrinology. 1999. Vol. 140. № 1. P. 286-291.